 Cross Reactions
"Cross Reactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
| Descriptor ID |
D003429
|
| MeSH Number(s) |
G12.425.143.281
|
| Concept/Terms |
Cross Reactions- Cross Reactions
- Cross Reaction
- Reaction, Cross
- Reactions, Cross
|
Below are MeSH descriptors whose meaning is more general than "Cross Reactions".
Below are MeSH descriptors whose meaning is more specific than "Cross Reactions".
This graph shows the total number of publications written about "Cross Reactions" by people in this website by year, and whether "Cross Reactions" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 3 | 3 | | 1981 | 0 | 2 | 2 | | 1983 | 0 | 1 | 1 | | 1984 | 0 | 3 | 3 | | 1985 | 0 | 1 | 1 | | 1986 | 0 | 6 | 6 | | 1987 | 0 | 1 | 1 | | 1989 | 0 | 1 | 1 | | 1990 | 1 | 1 | 2 | | 1991 | 0 | 4 | 4 | | 1993 | 0 | 2 | 2 | | 1994 | 0 | 5 | 5 | | 1997 | 0 | 1 | 1 | | 1998 | 0 | 1 | 1 | | 1999 | 0 | 2 | 2 | | 2000 | 0 | 2 | 2 | | 2001 | 0 | 4 | 4 | | 2002 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 2004 | 0 | 2 | 2 | | 2005 | 0 | 2 | 2 | | 2006 | 0 | 2 | 2 | | 2008 | 0 | 2 | 2 | | 2009 | 0 | 1 | 1 | | 2010 | 0 | 3 | 3 | | 2011 | 0 | 3 | 3 | | 2012 | 0 | 4 | 4 | | 2013 | 0 | 5 | 5 | | 2014 | 1 | 2 | 3 | | 2015 | 1 | 2 | 3 | | 2016 | 1 | 2 | 3 | | 2017 | 0 | 1 | 1 | | 2018 | 1 | 4 | 5 | | 2019 | 1 | 1 | 2 | | 2020 | 0 | 3 | 3 | | 2021 | 0 | 6 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Cross Reactions" by people in Profiles.
-
Arunkumar GA, Bhavsar D, Li T, Strohmeier S, Chromikova V, Amanat F, Bunyatov M, Wilson PC, Ellebedy AH, Boons GJ, Simon V, de Vries RP, Krammer F. Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus. Nat Commun. 2021 10 25; 12(1):6161.
-
Tan J, O'Dell G, Hernandez MM, Sordillo EM, Kahn Z, Kriti D, van Bakel H, Ellebedy AH, Wilson PC, Simon V, Krammer F, McMahon M. Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model. J Virol. 2022 01 26; 96(2):e0142121.
-
Dugan HL, Stamper CT, Li L, Changrob S, Asby NW, Halfmann PJ, Zheng NY, Huang M, Shaw DG, Cobb MS, Erickson SA, Guthmiller JJ, Stovicek O, Wang J, Winkler ES, Madariaga ML, Shanmugarajah K, Jansen MO, Amanat F, Stewart I, Utset HA, Huang J, Nelson CA, Dai YN, Hall PD, Jedrzejczak RP, Joachimiak A, Krammer F, Diamond MS, Fremont DH, Kawaoka Y, Wilson PC. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets. Immunity. 2021 06 08; 54(6):1290-1303.e7.
-
Hassani D, Amiri MM, Maghsood F, Salimi V, Kardar GA, Barati O, Hashemian SMR, Jeddi-Tehrani M, Zarnani AH, Shokri F. Does prior immunization with measles, mumps, and rubella vaccines contribute to the antibody response to COVID-19 antigens? Iran J Immunol. 2021 03; 18(1):47-53.
-
Chan CW, Shahul S, Coleman C, Tesic V, Parker K, Yeo KJ. Evaluation of the Truvian Easy Check COVID-19 IgM/IgG Lateral Flow Device for Rapid Anti-SARS-CoV-2 Antibody Detection. Am J Clin Pathol. 2021 02 04; 155(2):286-295.
-
Guthmiller JJ, Stovicek O, Wang J, Changrob S, Li L, Halfmann P, Zheng NY, Utset H, Stamper CT, Dugan HL, Miller WD, Huang M, Dai YN, Nelson CA, Hall PD, Jansen M, Shanmugarajah K, Donington JS, Krammer F, Fremont DH, Joachimiak A, Kawaoka Y, Tesic V, Madariaga ML, Wilson PC. SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike. mBio. 2021 01 19; 12(1).
-
Boughter CT, Borowska MT, Guthmiller JJ, Bendelac A, Wilson PC, Roux B, Adams EJ. Biochemical patterns of antibody polyreactivity revealed through a bioinformatics-based analysis of CDR loops. Elife. 2020 11 10; 9.
-
Kirkpatrick E, Henry C, McMahon M, Jiang K, Strohmeier S, van Bakel H, Wilson PC, Krammer F. Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity. J Virol. 2020 11 09; 94(23).
-
Guthmiller JJ, Lan LY, Fernández-Quintero ML, Han J, Utset HA, Bitar DJ, Hamel NJ, Stovicek O, Li L, Tepora M, Henry C, Neu KE, Dugan HL, Borowska MT, Chen YQ, Liu STH, Stamper CT, Zheng NY, Huang M, Palm AE, García-Sastre A, Nachbagauer R, Palese P, Coughlan L, Krammer F, Ward AB, Liedl KR, Wilson PC. Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses. Immunity. 2020 12 15; 53(6):1230-1244.e5.
-
Harris KM, Horn SE, Grant ML, Lang H, Sani G, Jensen-Wachspress MA, Kankate VV, Datar A, Lazarski CA, Bollard CM, Keller MD. T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1. Front Immunol. 2020; 11:575977.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|